ArticleCancer research2026

The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition.

Hetika Vora Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.